This is from the latest presentation at Euroz Hartleys Healthcare conference July 27.
Data on BTX1702 and BTX1204A expected this quarter.
Doggie derm has been delayed long enough, so they need to come up with theses goods, this quarter.
What has skipped ahead seems to be the BTX1702 as I thought the data from BTX1204A was meant to guide the BTX1702 trial.
Maybe they saw enough of what they wanted to see and just advanced BTX1702 ?
Good data from both of these this month is what we and management desperately need.
This is from the latest presentation at Euroz Hartleys...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.005(2.04%) |
Mkt cap ! $393.7M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.5¢ | 24.5¢ | $823.6K | 3.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 292257 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 67065 | 3 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.0¢ |
Change
0.005 ( 3.22 %) |
||||
| Open | High | Low | Volume | ||
| 24.5¢ | 25.5¢ | 24.5¢ | 1596484 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| BOT (ASX) Chart |